Loading chat...
NY A09075
Bill
Status
Introduced
2/6/2024
Primary Sponsor
Amanda Septimo
Click for details
AI Summary
- Mandates full coverage for comprehensive genetic testing and FDA-approved biomarker testing for prostate and ovarian cancers when recommended by a doctor, board-certified geneticist, or board-certified genetic counselor
- Requires coverage to be provided both before and after a patient's initial cancer diagnosis
- Eliminates annual deductibles and coinsurance for all costs associated with genetic testing, with expenses borne solely by the insurer
- Extends genetic screening coverage to family members of prostate and ovarian cancer patients and prohibits insurers from using genetic test results against family members for coverage purposes
- Applies to all health insurance policies, contracts, and certificates issued or renewed 60 days after the act becomes law
Legislative Description
Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.
Last Action
referred to insurance
2/6/2024
Committee Referrals
Insurance2/6/2024
Full Bill Text
No bill text available